Navigation Links
Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*
Date:3/24/2009

ANTONY, France, March 24 /PRNewswire-FirstCall/ -- Stallergenes S.A. and Solvay Pharmaceuticals Marketing and Licensing AG (subsidiary of Solvay Group) announce the signing of an exclusive partnership agreement for the promotion and distribution of Stallergenes diagnostic and treatment products in Russia and the Commonwealth of Independent States (CIS).

With an estimated 20 million allergy sufferers and a strong demand on the part of the medical community for quality products, the Russian market represents a real opportunity for Stallergenes.

The main products in Stallergenes' injectable and sublingual ranges will soon be the subject of registration applications. This partnership will enable Stallergenes to meet more than 80% of the needs of allergy sufferers in Russia and the CIS by 2011.

"We're delighted to be teaming up with Solvay Pharmaceuticals to target the potential growth this new market represents. Thanks to its franchise and its considerable expertise recognized by allergy specialists, Solvay Pharmaceuticals will enable us to promote the desensitization standardized products, and notably the sublingual route, and their benefits for patients," declared Albert Saporta, Stallergenes' Chairman and CEO.

"We're tremendously enthusiastic about the prospect of collaborating with the world leader in sublingual desensitization therapy and making its innovative standardized products available to practitioners," emphasizes Mr. Jens Neuschaefer, Vice President, Regional Director, Solvay Pharmaceuticals.

*countries concerned: Russia, Georgia, CIS (Commonwealth of Independent States: Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldavia, Uzbekistan, Russia, Tajikistan, Turkmenistan, and Ukraine).

About Stallergenes' International Development

Today, Stallergenes markets its products in more than 50 different countries, via 11 subsidiar
'/>"/>

SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
2. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
3. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
4. Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World
5. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
6. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
7. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
8. STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
9. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
10. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
11. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 The  PROPEL Center  of the  iBIO ... rate of early-stage life sciences companies in ... 15 grants to help Illinois ...   in Chicago .   AdvaMed ... North America , bringing more than 1,000 ...
(Date:8/1/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... MARKETS , that the global market RNA interference (RNAi) ... $38.8 billion by 2018, with a five-year compound annual ... the fastest moving segment of the market, is moving ... RNAi therapeutics has shown tremendous growth and has moved ...
(Date:7/31/2014)... Food and natural product manufacturers, ... food alternatives that offer variety, as well as, ... market has numerous players operating in the marketplace ... Technology (VFT). VFT is a science-driven functional ... all tested to produce stable, effective and repeatable ...
(Date:7/31/2014)... 60 are not donor candidates for bone marrow transplantation. ... the elderly prone to life-threatening infection and other maladies, ... discovered a reason why. , "We have found the ... to maintain blood production over time in an old ... restored for rejuvenation therapies," said Emmanuelle Passegu, PhD, a ...
Breaking Biology Technology:iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 3iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 4Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 2Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 3Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2Key to aging immune system is discovered 2
... Martek Biosciences,Corporation (Nasdaq: MATK ) today announced ... ended October 31, 2008. Revenues for the fourth,quarter were ... fourth quarter of,fiscal 2007. Net income was $10.5 million, ... fiscal 2008 compared with $18.3 million, or $0.55 per,diluted ...
... The University of,Minnesota has received a $40 ... Foundation. Goals for the funding, to be paid over,five ... and to accelerate the timeline to translate it into a ... The gift is the second largest ...
... Olympus has further,cemented its position as a leader ... exclusive and immediate deal to distribute the products of,Irish ... global,provider of ports for state-of-the-art laparoscopic operative techniques via,a ... now the exclusive,distributor for the full range of products ...
Cached Biology Technology:Martek Announces Fourth Quarter and FY 2008 Financial Results 2Martek Announces Fourth Quarter and FY 2008 Financial Results 3Martek Announces Fourth Quarter and FY 2008 Financial Results 4Martek Announces Fourth Quarter and FY 2008 Financial Results 5Martek Announces Fourth Quarter and FY 2008 Financial Results 6Martek Announces Fourth Quarter and FY 2008 Financial Results 7Martek Announces Fourth Quarter and FY 2008 Financial Results 8Martek Announces Fourth Quarter and FY 2008 Financial Results 9Martek Announces Fourth Quarter and FY 2008 Financial Results 10Martek Announces Fourth Quarter and FY 2008 Financial Results 11University of Minnesota Receives $40 Million for Type 1 Diabetes Research 2University of Minnesota Receives $40 Million for Type 1 Diabetes Research 3University of Minnesota Receives $40 Million for Type 1 Diabetes Research 4Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts 2
(Date:7/31/2014)... researchers have completed a 20-year study that looks ... at different times of the year. It finds ... time frame has no measurable negative consequences for ... benefits. , The study was conducted by Gene ... Station fire chief, and Joseph Craine, research assistant ...
(Date:7/31/2014)... exposure to loud noise alters how the brain ... speech sounds, according to neuroscientists at The University ... published this week in Ear and Hearing ... noise-induced hearing loss affects the brain,s recognition of ... all corners of the population, affecting an estimated ...
(Date:7/31/2014)... New Orleans, LA Dr. Oren Tessler, Assistant Professor ... Orleans School of Medicine, is part of a team ... success rate using a method to screen and select ... than 90% of the patients who underwent this surgery ... and also got a bonus cosmetic eyelid surgery. The ...
Breaking Biology News(10 mins):Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3UT Dallas study reveals effect of loud noises on brain 2Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2
... in green tea renowned for their powerful antioxidant ... the eye. Their new report, the first documenting how ... substances, raises the possibility that green tea may protect ... in ACS, bi-weekly Journal of Agricultural and Food ...
... Washington, DC A Georgetown University Medical Center ... National Institute on Drug Abuse to discover and develop ... about nicotine addiction. Kenneth Kellar, PhD, a professor ... five year grant totaling $4.6 million. The theory, ...
... April 2010) -- Ultrasound pioneer Gerald J. Posakony was ... award in the engineering profession on Monday night ... Posakony,s pioneering contributions to the fields of ultrasonics, ... during AAES, 31st annual awards ceremony at the Great ...
Cached Biology News:GUMC to develop smoking cessation aids based on unconventional nicotine addiction theory 2Ultrasound pioneer receives highest award in engineering profession 2Ultrasound pioneer receives highest award in engineering profession 3Ultrasound pioneer receives highest award in engineering profession 4Ultrasound pioneer receives highest award in engineering profession 5Ultrasound pioneer receives highest award in engineering profession 6
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
...
Proliferin (C-14)...
... & Cast submarine gel systems used gasketed gel trays. ... in the tank. Turn it back and run the ... convenience, each Turn & Cast tray is UV transparent. ... edge of the tray and one in the center. ...
Biology Products: